Why is Bliss GVS Pharma falling/rising?

As of 30-Jun, Bliss GVS Pharma Ltd's stock price is currently at Rs 158.60, reflecting an increase of Rs 1.55 or 0.99%. The stock has shown strong performance recently, gaining 6.44% over the last two days and outperforming its sector by 0.3%. It has also outperformed the benchmark Sensex in the short term, with a 7.16% increase over the past week compared to the Sensex's 2.09%. Despite a year-to-date decline of 3.67%, the stock has generated a remarkable return of 56.56% over the past year. However, it is important to note that the company's profits have fallen by 19.5% over the same period, and it has reported negative results for the last three consecutive quarters, which may raise concerns among investors.
In the broader market context, Bliss GVS Pharma's recent performance contrasts with the Sensex's 2.65% increase over the past month and 7.00% year-to-date. While the stock has shown strong returns in the short term and long term, its poor long-term growth, indicated by a -2.54% annual operating profit growth over the last five years, may temper investor enthusiasm. Additionally, the low participation from domestic mutual funds, holding only 0% of the company, suggests a lack of confidence in its valuation or business prospects. Overall, while the stock is currently rising, underlying financial challenges and market perceptions could impact its future performance.